Provided by Tiger Trade Technology Pte. Ltd.

BridgeBio Pharma, Inc.

75.15
+1.091.46%
Post-market: 74.67-0.4800-0.64%19:39 EST
Volume:1.60M
Turnover:119.10M
Market Cap:14.48B
PE:-17.96
High:75.24
Open:73.83
Low:72.65
Close:74.07
52wk High:75.24
52wk Low:25.34
Shares:192.71M
Float Shares:151.20M
Volume Ratio:0.93
T/O Rate:1.06%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.1844
EPS(LYR):-2.8793
ROE:-1789.67%
ROA:-43.47%
PB:-7.49
PE(LYR):-26.10

Loading ...

Apr 14, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 02, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 17, 2025

Major Issues Report

Form 8-K - Current report
Mar 06, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 05, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 28, 2025

Major Issues Report

Form 8-K - Current report
Feb 25, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 25, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 20, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 20, 2025

Major Issues Report

Form 8-K - Current report
Feb 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 31, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 28, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 28, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 13, 2025

Major Issues Report

Form 8-K - Current report
Nov 25, 2024

Major Issues Report

Form 8-K - Current report
Nov 19, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 19, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 12, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]